L. Vaessen

发表

Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients.

M. Welters, A. Bogers, W. Weimar, 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Circulating donor-speci ® c cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients q

M. Welters, A. Bogers, W. Weimar, 2000 .

Calcineurin Inhibitor Withdrawal in Stable Kidney Transplant Patients Decreases the Donor-Specific Cytotoxic T Lymphocyte Precursor Frequency

W. Weimar, J. Rischen‐Vos, P. de Kuiper, 2005, Transplantation.

The frequency of interferon-gproducing cells reflects alloreactivity against minor histocompatibility antigens

W. Weimar, J. Ijzermans, P. H. van der Meide, 2003, Transplantation.

Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.

W. Weimar, J. Ijzermans, T. van Gelder, 2000, Transplantation.

Peripheral blood manipulation significantly affects the result of dendritic cell monitoring.

W. Weimar, M. Klepper, L. Vaessen, 2007, Transplant immunology.

Donor-specific cellular immune response against human cardiac valve allografts.

A. Bogers, W. Weimar, C. Wassenaar, 1996, The Journal of thoracic and cardiovascular surgery.

A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts.

M. Welters, A. Bogers, F. Claas, 2002, Human immunology.

A size-matching heterotopic aortic valve implantation model in the rat.

M. Welters, A. Bogers, W. Weimar, 1999, The Journal of surgical research.

REASSURING EFFECT OF PRAVASTATIN ON NATURAL KILLER CELL ACTIVITY IN STABLE RENAL TRANSPLANT PATIENTS

W. Weimar, J. Ijzermans, T. van Gelder, 2001, Transplantation.

Phenotypic analysis of lymphocytes infiltrating human cardiac allografts during acute rejection and the development of graft vascular disease

W. Weimar, A. Balk, B. Mochtar, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

Induction of cytotoxic T lymphocytes with destructive potential after cardiac valve homograft implantation.

M. Welters, A. Bogers, W. Weimar, 2000, The Journal of heart valve disease.

Increased numbers of circulating donor‐specific T helper lymphocytes after human heart valve transplantation

W. Weimar, F. Oei, L. Vaessen, 2001, Clinical and experimental immunology.

A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation.

R. Zietse, W. Weimar, P. Zondervan, 1996, Transplantation.

Down‐regulated donor‐specific T‐cell reactivity during successful tapering of immunosuppression after kidney transplantation

W. Weimar, J. Ijzermans, T. Gelder, 2002, Clinical and experimental immunology.

T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapy.

W. Weimar, J. Ijzermans, T. van Gelder, 2001, Transplantation proceedings.

Donor-specific CTL frequencies in peripheral blood in relation to graft vascular disease after clinical heart transplantation

W. Weimar, A. Balk, B. Mochtar, 1998 .

Changes in immunological parameters after conversion from cyclosporine A to azathioprine in renal transplant recipients.

W. Weimar, L. Vaessen, A. Bijma, 1989, International journal of immunopharmacology.

Heart valve dysfunction resulting from cellular rejection in a novel heterotopic transplantation rat model

M. Welters, A. Bogers, W. Weimar, 2000, Transplant international : official journal of the European Society for Organ Transplantation.

Cytomegalovirus infection and allospecific cytotoxic activity of graft‐infiltrating cells after heart transplantation

F. Claas, W. Weimar, A. Balk, 1994, Journal of medical virology.

Prophylactic therapy with OKT3 does not affect donor specific reactivity of peripheral blood lymphocytes from heart transplant recipients.

F. Claas, W. Weimar, A. Balk, 1994, Transplant Immunology.

A DOUBLE‐BLIND, PLACEBO‐CONTROLLED STUDY OF MONOCLONAL ANTI‐INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) ADMINISTRATION TO PREVENT ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION

R. Zietse, W. Weimar, T. Gelder, 1995, Transplantation.

Immune monitoring of heart transplant patients receiving either one or two cycles of OKT3 prophylaxis. Induced anti-idiotypic and anti-isotypic anti-OKT3 antibodies do not prohibit depletion of peripheral T cells due to second OKT3 treatment

W. Weimar, A. Balk, B. Mochtar, 1991 .

Donor‐specific CTL frequencies in peripheral blood in relation to graft vascular disease after clinical heart transplantation

W. Weimar, A. Balk, B. Mochtar, 1998, Transplant international : official journal of the European Society for Organ Transplantation.

Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathways

F. Claas, W. Weimar, A. Balk, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

Immunological aspects of fresh and cryopreserved aortic valve transplantation in rats.

A. Bogers, W. Weimar, R. Marquet, 2001, Annals of Thoracic Surgery.

A longitudinal study of TGF‐β1 protein levels in renal allograft recipients converted from CsA to MMF or AZA

W. Weimar, T. van Gelder, L. Vaessen, 2000, Clinical transplantation.

Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.

R. Zietse, W. Weimar, T. van Gelder, 1996, Transplantation Proceedings.

Acute rejection in heart transplant patients is associated with the presence of committed donor‐specific cytotoxic lymphocytes in the graft but not in the blood

W. Weimar, B. Mochtar, C. Baan, 1992, Clinical and experimental immunology.

The effects of renal transplantation on circulating dendritic cells

W. Hop, W. Weimar, D. Hesselink, 2005, Clinical and experimental immunology.

Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.

F. Claas, W. Weimar, J. Ijzermans, 2001, Transplantation.